SLC6A3 and Lewy body dementia: Table 3 integrates key findings from the Chahid et al. review with additional details on the mechanism of action and clinical uses of various medications relevant to DLB, offering a comprehensive overview of pharmacological considerations and their implications for DAT SPECT imaging.